Using the Zwolle Risk Score at Time of Coronary Angiography to Triage Patients With ST-Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention or Thrombolysis.
PCI
STEMI
ST‐elevation myocardial infarction
Zwolle risk score
cardiac intensive care
percutaneous coronary intervention
quality
thrombolytics
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
15 02 2022
15 02 2022
Historique:
pubmed:
9
2
2022
medline:
9
4
2022
entrez:
8
2
2022
Statut:
ppublish
Résumé
Background The Zwolle Risk Score was designed to identify the risk of complications in patients with ST-segment‒elevation myocardial infarction (STEMI) following percutaneous coronary intervention (PCI). Its utility following PCI in STEMI treated with thrombolysis is unknown. The objective was to evaluate the safety of using the Zwolle Risk Score to triage patients with STEMI following PCI, including patients receiving thrombolysis. Methods and Results Patients aged ≥18 years with STEMI and primary PCI or PCI after thrombolysis were included. A triage protocol was developed, with high-risk patients those with Zwolle Risk Score ≥4 triaged to the cardiac intensive care unit. A prospective evaluation of the triaging protocol was performed on 452 patients, mean age 65±12 years, 73% men. Median Zwolle Risk Score was 3 (interquartile range, 2‒5), with 257 low-risk (57%), and 195 high-risk (43%) patients. Adherence to the protocol was 91%. In-hospital mortality was 0.4% in low-risk and 13% in high-risk patients (
Identifiants
pubmed: 35132867
doi: 10.1161/JAHA.121.024759
pmc: PMC9245809
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e024759Références
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Circulation. 2000 Oct 24;102(17):2031-7
pubmed: 11044416
Heart Lung Circ. 2021 Apr;30(4):489-495
pubmed: 33277179
Circ Cardiovasc Interv. 2020 Jan;13(1):e008290
pubmed: 31884835
JAMA. 2012 Jan 4;307(1):66-74
pubmed: 22215167
Can J Cardiol. 2017 Jan;33(1):166-169
pubmed: 27914806
Am Heart J. 2016 Jul;177:145-52
pubmed: 27297860
Lancet. 1998 Nov 28;352(9142):1771-4
pubmed: 9848369
Rev Esp Cardiol. 2009 Dec;62(12):1356-64
pubmed: 20038401
J Am Coll Cardiol. 1998 Apr;31(5):967-72
pubmed: 9561995
J Am Heart Assoc. 2018 May 25;7(11):
pubmed: 29802146
Am Heart J. 2008 Dec;156(6):1026-34
pubmed: 19032996
EuroIntervention. 2014 Jan 22;9(9):1095-101
pubmed: 24457280
Eur Heart J. 2005 Aug;26(16):1676-82
pubmed: 15781435
Circulation. 2004 Jun 8;109(22):2737-43
pubmed: 15159293
Can J Cardiol. 2011 Sep-Oct;27(5):664.e1-8
pubmed: 21803534
N Engl J Med. 2012 Oct 4;367(14):1287-96
pubmed: 22920912
Catheter Cardiovasc Interv. 2006 Feb;67(2):214-20
pubmed: 16408298
JACC Cardiovasc Interv. 2019 Apr 22;12(8):718-720
pubmed: 31000009
Am J Med. 2018 Jan;131(1):100.e9-100.e20
pubmed: 28801225
Intensive Care Med. 2020 Jul;46(7):1303-1325
pubmed: 32514598
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004553
pubmed: 29654000
N Engl J Med. 2008 Jul 10;359(2):142-51
pubmed: 18614781
JACC Cardiovasc Interv. 2019 Apr 22;12(8):709-717
pubmed: 31000008
JAMA. 2001 Sep 19;286(11):1356-9
pubmed: 11560541